The role of alcohol-associated microbiota membrane vesicles in mucosal immunity
The role of alcohol-associated microbiota membrane vesicles in mucosal immunity
批准号:
10751767
负责人:
Daniel Villageliu
金额:
$7.1万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-28 至 2026-04-27
关键词:
AccountingAddressAlcohol consumptionAlcoholsBacteriaBacterial Antibiotic ResistanceBacterial PneumoniaBiologicalCellsChemicalsChronicCirrhosisClostridiumDataDevelopmentDiseaseEpitheliumEthanolExcretory functionFrequenciesFunctional disorderFutureGastrointestinal tract structureGoalsGrowthHealthHost DefenseHumanIn VitroIndividualIndolesInfectionInflammationInflammatoryInterleukin-1Interleukin-6IntestinesKlebsiella pneumoniaeLungLung immune responseMalignant NeoplasmsMediatingMembraneMembrane PotentialsMorbidity - disease rateMucosal ImmunityMucous MembraneMusPathogenesisPathogenicityPredispositionPropertyProteomicsResearchRespiratory SystemRespiratory Tract InfectionsRiskRoleSamplingSourceStreptococcus pneumoniaeStressSubstance Use DisorderTNF geneTestingTherapeuticTherapeutic InterventionTryptophanVesiclealcohol effectalcohol exposurealcohol misusealcohol use disordercytokinedietarydisability-adjusted life yearsdysbiosiseffector T cellgut microbesgut microbiotahost-microbe interactionsimprovedinfancyinsightmetabolomicsmicrobialmicrobiotamortalitynovelnovel therapeuticspathogentissue injuryyears of life lost
中文摘要
AUD(酒精使用障碍)的全球负担的很大一部分来自风险增加,
易患疾病,包括感染、肝硬化和癌症。这些疾病是受
肠道微生物群的组成,这是由酒精的使用改变。尽管大家都认为
微生物群的变化有助于AUD的疾病建立和进展,我们对
发生这种情况的机制是不充分的。这些机制可能涉及各种微生物群-
衍生产物(膜囊泡、排泄的化学物质、细胞组分、LPS等)。初步数据
本文提出的支持微生物来源的膜囊泡(MV)是一个重要的
酒精导致的组织损伤
为了解决这一可能性,本提案将研究酒精对以下物质的组成和频率的影响:
微生物群衍生的MV。该提案还将评估与酒精相关的MV对促进
组织损伤和粘膜感染。我们的初步数据表明,酒精改变了MV的组成
由肠道微生物群产生,并且孤立的酒精相关MV增加了对呼吸道感染的易感性。
感染,独立于酒精的使用,这表明MV影响粘膜宿主防御。我们假设
来自酒精相关微生物群的MV将具有增加的炎症特性,并增加
通过上皮炎症和屏障功能障碍对粘膜感染易感。了解
酒精暴露后细菌MV的改变可能会对疾病的发病机制提供新的见解,
可能会激发未来以调节MV为中心的治疗方法。
英文摘要
A significant portion of the global burden of AUD (Alcohol use disorder) derives from an increased risk and
susceptibility to diseases including infection, cirrhosis, and cancer. These diseases are influenced by the
composition of the intestinal microbiota, which is altered by alcohol use. Though it has been accepted that
change to the microbiota contributes to disease establishment and progression in AUD, our understanding of
the mechanisms by which this occurs is inadequate. These mechanisms likely involve a variety of microbiota-
derived products (membrane vesicles, excreted chemicals, cellular components, LPS, etc.). The preliminary data
addressed herein support the proposition that microbiota-derived membrane vesicles (MVs) are an important
driver of alcohol-driven tissue injury.
To address this possibility, this proposal will examine the effects of alcohol on the composition and frequency of
microbiota derived MVs. This proposal will also evaluate the effects of alcohol-associated MVs on promoting
tissue injury and mucosal infection. Our preliminary data demonstrate that alcohol alters the composition of MVs
generated by the gut microbiota, and that isolated alcohol-associated MVs increase susceptibility to respiratory
infection, independent of alcohol use, suggesting that MVs influence mucosal host defense. We hypothesize that
MVs from an alcohol-associated microbiota will have increased inflammatory properties and increase
susceptibility to mucosal infections via epithelial inflammation and barrier dysfunction. Understanding the
alterations to bacterial MVs following alcohol exposure may give new insight into disease pathogenesis, which
may inspire future therapies centered on modulating MVs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金